The FINANCIAL — Astellas Pharma Inc. on September 18 announced that it has been selected for the fifth consecutive year as an index component of the Dow Jones Sustainability Asia Pacific Index, the Asia Pacific version of the Dow Jones Sustainability Indices (“DJSI”) and one of the world’s premier indices for Socially Responsible Investment .
The DJSI, launched jointly by Dow Jones & Company of the United States and RobecoSAM AG of Switzerland, is a leading SRI index which assesses and selects leading sustainability-driven companies in terms of economic, environmental, and social criteria.
Specifically designed for companies in the developed Asia Pacific markets including Japan, the Dow Jones Sustainability Asia Pacific Index has selected 145 companies, including 62 Japanese companies, which are leading the way in terms of sustainability among 600 companies in the region, according to Astellas Pharma.
Through a wide range of CSR activities, Astellas will continue to strive to create and protect social value, contribute to the sustainable development of society and consequently enhance its enterprise value.
Discussion about this post